Lyon Joseph Douglas

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$5.2M

Insider Activity of Lyon Joseph Douglas

According to the SEC Form 4 filings, Lyon Joseph Douglas, being in a position of

  1. See Remarks at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 36411 share for $1.04M,
    over all time since 2020-12-30, has bought 0 shares, and sold 193843 shares for $5.2M.

The largest sale of all time was on 2021-02-03 and amounted to 25000 shares of Corcept Therapeutics Incorporated for $729,570.

Biography of Lyon Joseph Douglas

No biography is available at this moment.

2024-11-22SaleCorcept Therapeutics Incorporated
CORT
See Remarks
1,411
0.0013%
$56.72$80,032+2.02%
2024-07-01SaleCorcept Therapeutics Incorporated
CORT
See Remarks
5,000
0.0049%
$32.49$162,4520%
2024-06-03SaleCorcept Therapeutics Incorporated
CORT
See Remarks
5,000
0.0046%
$30.18$150,916+32.86%
2024-05-09SaleCorcept Therapeutics Incorporated
CORT
See Remarks
7,227
0.0068%
$26.00$187,902+33.17%
2024-05-02SaleCorcept Therapeutics Incorporated
CORT
See Remarks
10,830
0.0109%
$26.00$281,580+40.22%
2024-04-04SaleCorcept Therapeutics Incorporated
CORT
See Remarks
5,443
0.0055%
$26.00$141,524+37.64%
2024-04-01SaleCorcept Therapeutics Incorporated
CORT
See Remarks
500
0.0005%
$26.01$13,004+33.92%
2024-02-16SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
1,000
0.0011%
$26.00$26,000+46.81%
2023-12-04SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
2,432
0.0023%
$26.00$63,232+10.49%
2023-11-02SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
3,977
0.0043%
$28.11$111,794+5.06%
2023-11-01SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
1,023
0.001%
$28.08$28,726-5.59%
2023-10-06SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
2,582
0.0026%
$27.24$70,334+0.83%
2023-10-02SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
2,418
0.0024%
$27.25$65,889+0.72%
2023-09-01SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
5,000
0.0049%
$32.73$163,650-20%
2023-08-21SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
4,588
0.0045%
$31.19$143,100-15.64%
2023-08-07SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
412
0.0004%
$31.22$12,863-11.94%
2023-06-06SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
10,000
0.0093%
$23.60$236,000+7.49%
2021-04-01SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
25,000
0.021%
$23.88$597,030-13.14%
2021-03-01SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
25,000
0.0212%
$25.21$630,320-16.65%
2021-02-03SaleCorcept Therapeutics Incorporated
CORT
Chief Accounting Officer
25,000
0.0215%
$29.18$729,570-26.27%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.